$HEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AIM ImmunoTech Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AIM ImmunoTech Inc.. Get notifications about new insider transactions in AIM ImmunoTech Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 10,861 | 0 | 10,861 | |
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 10,861 | 0 | 10,861 | |
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 19,016 | 0 | 19,016 | |
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 11,948 | 0 | 11,948 | |
| May 03 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 12,143 | 0 | 12,143 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | A | 0.00 | 11,696 | 0 | 11,696 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | A | 0.00 | 9,503 | 0 | 9,503 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | A | 0.00 | 10,137 | 0 | 10,137 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | A | 0.00 | 12,671 | 0 | 12,671 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 11,696 | 0 | 11,696 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 9,503 | 0 | 9,503 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 10,137 | 0 | 10,137 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 12,671 | 0 | 12,671 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 11,696 | 0 | 11,696 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 9,503 | 0 | 9,503 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 10,137 | 0 | 10,137 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 12,671 | 0 | 12,671 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 20,479 | 0 | 20,479 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 16,639 | 0 | 16,639 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 16,915 | 0 | 16,915 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 18,714 | 0 | 18,714 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 12,867 | 0 | 12,867 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 10,454 | 0 | 10,454 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 11,151 | 0 | 11,151 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 13,939 | 0 | 13,939 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 13,077 | 0 | 13,077 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,625 | 0 | 10,625 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
| Apr 06 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 10,694 | 0 | 10,694 | |
| Mar 21 2016 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CEO,Pres,Exec Vice ... | Buy | P | 0.13 | 30,000 | 3,966 | 1,484,548 | 1.5 M to 1.5 M (+2.06 %) |
| Mar 14 2016 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CEO,Pres,Exec Vice ... | Buy | P | 0.16 | 10,000 | 1,618 | 10,000 | 0 to 10 K |
| Mar 14 2016 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CEO,Pres,Exec Vice ... | Buy | P | 0.16 | 30,000 | 4,692 | 30,000 | 0 to 30 K |
| Mar 10 2016 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CEO,Pres,Exec Vice ... | Buy | P | 0.16 | 30,000 | 4,890 | 30,000 | 0 to 30 K |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | A | 0.00 | 10,861 | 0 | 10,861 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.00 | 10,861 | 0 | 10,861 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EQHBAL | Director | Option Exercise | A | 0.00 | 10,861 | 0 | 10,861 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.00 | 19,016 | 0 | 19,016 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Sr VP of Operations | Option Exercise | A | 0.00 | 11,948 | 0 | 11,948 | |
| Apr 19 2016 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | CFO | Option Exercise | A | 0.00 | 12,143 | 0 | 12,143 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.51 | 491,196 | 250,510 | 0 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.25 | 150,000 | 37,500 | 0 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.29 | 100,000 | 29,000 | 0 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 2.60 | 320,000 | 832,000 | 0 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 4.03 | 10,000 | 40,300 | 0 | |
| Dec 14 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 2.71 | 73,728 | 199,803 | 0 | |
| Aug 20 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.18 | 25,000 | 4,488 | 1,225,585 | 1.2 M to 1.2 M (+2.08 %) |
| Aug 19 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.18 | 25,000 | 4,550 | 1,200,585 | 1.2 M to 1.2 M (+2.13 %) |
| Aug 18 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.18 | 25,000 | 4,538 | 1,175,585 | 1.2 M to 1.2 M (+2.17 %) |
| Aug 14 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Pres.,Sec., Vi ... | Buy | P | 0.18 | 50,000 | 9,005 | 1,384,548 | 1.3 M to 1.4 M (+3.75 %) |
| Aug 14 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Pres.,Sec., Vi ... | Buy | P | 0.18 | 12,600 | 2,268 | 1,334,548 | 1.3 M to 1.3 M (+0.95 %) |
| Aug 14 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Pres.,Sec., Vi ... | Buy | P | 0.18 | 16,504 | 2,967 | 1,321,948 | 1.3 M to 1.3 M (+1.26 %) |
| Jun 10 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.25 | 500,000 | 125,000 | 9,015,378 | |
| Jun 10 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO,Vice Chairman,S ... | Option Exercise | J | 0.25 | 300,000 | 75,000 | 2,050,000 | |
| Apr 29 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.24 | 100,000 | 24,200 | 1,150,585 | 1.1 M to 1.2 M (+9.52 %) |
| Apr 28 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Vice Chairman, ... | Buy | P | 0.24 | 100,000 | 24,430 | 1,305,444 | 1.2 M to 1.3 M (+8.30 %) |
| Apr 22 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.24 | 100,000 | 24,000 | 1,050,585 | 950.6 K to 1.1 M (+10.52 %) |
| Apr 21 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Vice Chairman, ... | Buy | P | 0.24 | 100,000 | 23,910 | 1,205,444 | 1.1 M to 1.2 M (+9.05 %) |
| Apr 20 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.23 | 73,681 | 16,947 | 950,585 | 876.9 K to 950.6 K (+8.40 %) |
| Apr 17 2015 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.23 | 26,319 | 6,053 | 876,904 | 850.6 K to 876.9 K (+3.09 %) |
| Apr 15 2015 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Vice Chairman, ... | Buy | P | 0.23 | 100,000 | 22,540 | 1,105,444 | 1 M to 1.1 M (+9.95 %) |
| Mar 24 2015 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Gift | G | 0.00 | 50,663 | 0 | 199,661 | 149 K to 199.7 K (+34.00 %) |
| Dec 09 2014 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | Chief Accounting Of ... | Option Exercise | J | 1.90 | 7,176 | 13,634 | 127,648 | |
| Dec 09 2014 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Option Exercise | J | 1.90 | 10,000 | 19,000 | 190,000 | ||
| Dec 09 2014 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | VP of Operations | Option Exercise | J | 1.90 | 1,812 | 3,443 | 288,900 | |
| Dec 09 2014 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 2.60 | 320,000 | 832,000 | 8,515,378 | |
| Sep 09 2014 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | J | 2.60 | 50,000 | 130,000 | 562,000 | |
| Jul 11 2014 | HEB | HEMISPHERX BIOPHAR ... | Pascale Adam | Chief Accounting Of ... | Option Exercise | J | 0.33 | 50,000 | 16,500 | 127,648 | |
| Jun 11 2014 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | VP of Operations | Option Exercise | J | 0.36 | 50,000 | 18,000 | 288,900 | |
| Jun 11 2014 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | CFO, Vice Chairman, ... | Option Exercise | J | 0.36 | 300,000 | 108,000 | 1,750,000 | |
| Jun 11 2014 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.36 | 500,000 | 180,000 | 8,515,378 | |
| Aug 06 2013 | HEB | HEMISPHERX BIOPHAR ... | Rodino Peter W. III | Director | Option Exercise | J | 0.25 | 150,000 | 37,500 | 150,000 | |
| Aug 02 2013 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | J | 0.25 | 150,000 | 37,500 | 562,000 | |
| Aug 02 2013 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Option Exercise | J | 0.25 | 150,000 | 37,500 | 332,000 | |
| Aug 02 2013 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Exec Vice Chairman, ... | Option Exercise | J | 0.25 | 150,000 | 37,500 | 1,450,000 | |
| Aug 02 2013 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.25 | 150,000 | 37,500 | 8,015,378 | |
| Jun 06 2013 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Exec Vice Chairman, ... | Option Exercise | J | 0.31 | 300,000 | 93,000 | 1,300,000 | |
| Jun 06 2013 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.31 | 500,000 | 155,000 | 7,865,378 | |
| May 09 2013 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | VP of Operations | Option Exercise | P | 0.24 | 50,000 | 12,000 | 238,900 | |
| Jan 16 2013 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 20,000 | 0 | 850,585 | 870.6 K to 850.6 K (-2.30 %) |
| Dec 21 2012 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 10,000 | 0 | 422,423 | 432.4 K to 422.4 K (-2.31 %) |
| Nov 21 2012 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 10,000 | 0 | 432,423 | 442.4 K to 432.4 K (-2.26 %) |
| Sep 20 2012 | HEB | HEMISPHERX BIOPHAR ... | Cavalli Ralph Christopher | VP, Quality Control | Option Exercise | J | 0.85 | 30,000 | 25,500 | 90,000 | |
| Aug 10 2012 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Buy | J | 0.26 | 368,345 | 95,770 | 630,886 | 262.5 K to 630.9 K (+140.30 %) |
| Jun 11 2012 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Vice Chairman of Bo ... | Option Exercise | J | 0.31 | 300,000 | 93,000 | 1,000,000 | |
| Jun 11 2012 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.31 | 500,000 | 155,000 | 7,365,378 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Option Exercise | J | 0.29 | 100,000 | 29,000 | 177,000 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | J | 0.29 | 100,000 | 29,000 | 412,000 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | PIANI RICHARD | Director | Option Exercise | J | 0.29 | 100,000 | 29,000 | 424,608 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Exec Vice Chairman ... | Option Exercise | J | 0.29 | 100,000 | 29,000 | 700,000 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.29 | 100,000 | 29,000 | 6,865,378 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Senior VP of Operat ... | Option Exercise | J | 0.29 | 50,000 | 14,500 | 188,900 | |
| Jun 07 2012 | HEB | HEMISPHERX BIOPHAR ... | Dickey Robert IV | Senior Vice Preside ... | Option Exercise | J | 0.29 | 50,000 | 14,500 | 200,000 | |
| May 21 2012 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Buy | P | 0.26 | 44,900 | 11,450 | 280,932 | 236 K to 280.9 K (+19.02 %) | |
| May 21 2012 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Buy | P | 0.26 | 5,100 | 1,301 | 236,032 | 230.9 K to 236 K (+2.21 %) | |
| May 11 2012 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Buy | J | 2.40 | 5,208 | 12,499 | 262,541 | 257.3 K to 262.5 K (+2.02 %) |
| May 11 2012 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Buy | J | 2.26 | 11,062 | 25,000 | 257,333 | 246.3 K to 257.3 K (+4.49 %) |
| Apr 16 2012 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Option Exercise | J | 4.03 | 10,000 | 40,300 | 190,000 | ||
| Apr 16 2012 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 4.03 | 10,000 | 40,300 | 6,765,378 | |
| Dec 22 2011 | HEB | HEMISPHERX BIOPHAR ... | Bernhardt Charles Thomas III | Chief Financial Off ... | Option Exercise | J | 0.31 | 100,000 | 31,000 | 200,000 | |
| Sep 26 2011 | HEB | HEMISPHERX BIOPHAR ... | Cavalli Ralph Christopher | VP, Quality Control | Option Exercise | J | 0.37 | 40,000 | 14,800 | 60,000 | |
| Jul 15 2011 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | J | 0.41 | 500,000 | 205,000 | 7,256,574 | |
| Jun 27 2011 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | General Counsel | Option Exercise | J | 0.41 | 300,000 | 123,000 | 1,091,196 | |
| May 31 2011 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | VP of Operations | Option Exercise | P | 0.55 | 90,000 | 49,500 | 138,900 | |
| Mar 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.46 | 25,000 | 11,488 | 207,983 | 183 K to 208 K (+13.66 %) |
| Mar 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.46 | 25,000 | 11,500 | 182,983 | 158 K to 183 K (+15.82 %) |
| Feb 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.50 | 200 | 100 | 157,983 | 157.8 K to 158 K (+0.13 %) |
| Feb 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.51 | 1,260 | 643 | 157,783 | 156.5 K to 157.8 K (+0.80 %) |
| Feb 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.52 | 1,000 | 520 | 156,523 | 155.5 K to 156.5 K (+0.64 %) |
| Feb 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.52 | 1,500 | 780 | 155,523 | 154 K to 155.5 K (+0.97 %) |
| Feb 03 2011 | HEB | HEMISPHERX BIOPHAR ... | Lander Russel J | VP of Process/Quali ... | Buy | P | 0.47 | 950 | 447 | 154,023 | 153.1 K to 154 K (+0.62 %) |
| Feb 01 2011 | HEB | HEMISPHERX BIOPHAR ... | Bernhardt Charles Thomas III | Chief Financial Off ... | Option Exercise | P | 0.55 | 100,000 | 55,000 | 100,000 | |
| Feb 01 2011 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Option Exercise | P | 2.71 | 73,728 | 199,803 | 6,756,574 | |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Sell | S | 0.50 | 1,129 | 561 | 890,585 | 891.7 K to 890.6 K (-0.13 %) |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.50 | 2,144 | 1,065 | 891,714 | 889.6 K to 891.7 K (+0.24 %) |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Sell | S | 0.48 | 26,519 | 12,756 | 889,570 | 916.1 K to 889.6 K (-2.89 %) |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Sell | S | 0.49 | 224,110 | 110,352 | 916,089 | 1.1 M to 916.1 K (-19.66 %) |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Sell | S | 0.50 | 125,630 | 63,066 | 1,140,199 | 1.3 M to 1.1 M (-9.92 %) |
| Aug 11 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.49 | 818,682 | 405,084 | 1,265,829 | 447.1 K to 1.3 M (+183.09 %) |
| Jul 01 2010 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Director | Option Exercise | P | 0.66 | 300,000 | 198,000 | 791,196 | |
| Jul 01 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.66 | 500,000 | 330,000 | 947,147 | 447.1 K to 947.1 K (+111.82 %) |
| Jun 25 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 10,813 | 0 | 447,147 | 458 K to 447.1 K (-2.36 %) |
| Jun 24 2010 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Sell | S | 0.55 | 9,748 | 5,362 | 230,932 | 240.7 K to 230.9 K (-4.05 %) | |
| Jun 24 2010 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Sell | S | 0.55 | 40,900 | 22,495 | 240,680 | 281.6 K to 240.7 K (-14.53 %) | |
| Jun 24 2010 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Sell | S | 0.56 | 252 | 141 | 281,580 | 281.8 K to 281.6 K (-0.09 %) | |
| Jun 16 2010 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Vice President of O ... | Sell | S | 0.59 | 83,104 | 49,114 | 103,521 | 186.6 K to 103.5 K (-44.53 %) |
| Jun 16 2010 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Vice President of O ... | Buy | P | 0.59 | 185,748 | 109,777 | 186,625 | 877 to 186.6 K (+21,179.93 %) |
| Jun 18 2010 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Buy | P | 0.58 | 230,586 | 132,587 | 281,832 | 51.2 K to 281.8 K (+449.96 %) | |
| Jun 16 2010 | HEB | HEMISPHERX BIOPHAR ... | Bernhardt Charles Thomas III | Chief Financial Off ... | Sell | S | 0.59 | 87,794 | 51,974 | 177,420 | 265.2 K to 177.4 K (-33.10 %) |
| Jun 16 2010 | HEB | HEMISPHERX BIOPHAR ... | Bernhardt Charles Thomas III | Chief Financial Off ... | Buy | P | 0.59 | 198,135 | 117,296 | 265,214 | 67.1 K to 265.2 K (+295.38 %) |
| Feb 25 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 5,000 | 0 | 457,960 | 463 K to 458 K (-1.08 %) |
| Feb 24 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 5,000 | 0 | 462,960 | 468 K to 463 K (-1.07 %) |
| Feb 24 2010 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 20,000 | 0 | 467,960 | 488 K to 468 K (-4.10 %) |
| Dec 16 2009 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Buy | P | 0.56 | 877 | 493 | 877 | 0 to 877 | |
| Dec 08 2009 | HEB | HEMISPHERX BIOPHAR ... | Dickey Robert IV | Senior Vice Preside ... | Buy | P | 0.64 | 2,500 | 1,600 | 2,500 | 0 to 2.5 K |
| Dec 08 2009 | HEB | HEMISPHERX BIOPHAR ... | Bernhardt Charles Thomas III | CFO | Buy | P | 0.56 | 2,000 | 1,126 | 67,079 | 65.1 K to 67.1 K (+3.07 %) |
| Dec 08 2009 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Buy | P | 0.57 | 12,000 | 6,785 | 51,246 | 39.2 K to 51.2 K (+30.58 %) | |
| Dec 07 2009 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Buy | P | 0.57 | 30,000 | 17,070 | 487,960 | 458 K to 488 K (+6.55 %) |
| Sep 30 2009 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Director | Grant | A | 2.10 | 7,714 | 16,199 | 7,714 | 0 to 7.7 K |
| Sep 30 2009 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Director | Grant | A | 2.12 | 11,741 | 24,891 | 11,741 | 0 to 11.7 K |
| Aug 13 2009 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 3,630 | 0 | 457,960 | 461.6 K to 458 K (-0.79 %) |
| Jun 30 2009 | HEB | HEMISPHERX BIOPHAR ... | CARTER WILLIAM A | CEO | Gift | G | 0.00 | 14,900 | 0 | 462,590 | 477.5 K to 462.6 K (-3.12 %) |
| Jun 12 2009 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Director | Grant | A | 0.55 | 68,182 | 37,500 | 68,182 | 0 to 68.2 K |
| Jun 26 2009 | HEB | HEMISPHERX BIOPHAR ... | Equels Thomas K. | Director | Grant | A | 0.50 | 99,483 | 49,742 | 99,483 | 0 to 99.5 K |
| Jun 12 2009 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Grant | A | 0.55 | 56,818 | 31,250 | 57 | -56,761 to 57 (-100.10 %) |
| Jun 12 2009 | HEB | HEMISPHERX BIOPHAR ... | KIANI IRAJ EGHBAL | Director | Grant | A | 0.55 | 56,818 | 31,250 | 56,818 | 0 to 56.8 K |
| Jun 12 2009 | HEB | HEMISPHERX BIOPHAR ... | PIANI RICHARD | Director | Grant | A | 0.55 | 56,818 | 31,250 | 56,818 | 0 to 56.8 K |
| Jun 04 2009 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Grant | A | 0.39 | 20,067 | 7,826 | 20,067 | 0 to 20.1 K | |
| Jun 05 2009 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Grant | A | 0.37 | 16,887 | 6,248 | 16,887 | 0 to 16.9 K | |
| Jun 05 2009 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Grant | A | 0.18 | 35,427 | 6,377 | 35,427 | 0 to 35.4 K | |
| Jun 05 2009 | HEB | HEMISPHERX BIOPHAR ... | Springate Wayne S. | Grant | A | 0.14 | 44,172 | 6,184 | 44,172 | 0 to 44.2 K |